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ABSTRACT
Hemodynamic loading, the force exerted on the cardiovascular walls as blood circulates,
has been shown to alter heart morphology in chick and zebrafish embryos, but has yet to
be shown to singly influence mouse heart development. Defects of heart morphology
found in model organisms with physically altered hemodynamics resemble the
aberrations seen in human congenital heart disease and are therefore crucial to understand
in a mammalian model. In the present study, hemodynamic loading was altered by
lowering the hematocrit of early stage mouse embryos. This was accomplished by
injecting acrylamide and TEMED into the blood islands of cultured embryos to create a
gel matrix which prevented blood cells from entering the circulatory system and thus
created a low-hemodynamic loading environment inside the embryo’s cardiovascular
system. The treatment was allowed to take affect for twenty-four hours in static culture,
followed by visualization using immunostaining and optical projection tomography. The
embryos with lowered hemodynamic loading displayed a decrease in heart volume size
and compact myocardial thickness, less defined trabeculation, and inhibition of cardiac
looping. Furthermore, the results showed an unexpected outcome, whereby acrylamideonly injections of the blood islands also resulted in some morphometric heart
abnormalities (trabeculation and looping). The results from this study suggest this could
be due to a slight reduction in red blood cell development, indicating a continuum by
which hemodynamic loading affects heart morphogenesis.
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INTRODUCTION

Heart Development
Cardiovascular development is an imperative part of embryogenesis because it
supplies the inner tissues of the organism with vital nutrients. In larger organisms,
passive diffusion of nutrients and oxygen into the cells is limited by the overall surface
area to volume ratio of the organism. For example, members of the phylum
Platyhelminthes (flat worm) are limited to a flattened body which allows for passive
diffusion of oxygen and nutrients (Jiang et al., 2013). Furthermore, in the phylum
Nematoda, organisms can develop larger bodies due to the presence of a psuedocoelom
(Atkinson, 1973), and chordates are capable of developing even larger bodies due to the
presence of a closed circulatory system which efficiently supplies nutrients and removes
waste from the organism’s body (Pittman, 2016). Due to the necessity of the circulatory
system in larger organisms, the first organ to develop during embryogenesis is therefore
the heart.
In early mouse development, once the embryo has developed thick tissues, simple
diffusion of oxygen and nutrients can no longer sustain the embryo and the circulatory
system is therefore mandatory for the delivery of essential nutrients into deep tissue
layers. At embryonic stage E6.5 (6.5 days after fertilization), heart progenitor cells are
first located on the rostral portion of the epiblast before they ingress through the primitive
streak and differentiate into cardiomyocytes (Tam et al., 1997). By E7.5, after ingression,
the cells form two distinct sections of splanchnic lateral plate mesoderm now known as
cardiogenic plates (Savolainen et al., 2009). A separate layer of endothelial cells will
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eventually form ventrally to the cardiogenic plate to become the inner lining of the heart
called the endocardium; however, there is much debate as to where these endothelial cell
arise (Haack and Abdelilah-Seyfried, 2016). There is evidence to support their
delamination from the cardiomyocytes in the cardiogenic plates (Devine et al., 2014;
Ferdous et al., 2009; Misfeldt et al., 2009), but there is also evidence suggesting the
endocardium is derived from vascular endothelial populations (Bussmann et al., 2007;
Keegan et al., 2004; Milgrom-Hoffman et al., 2011). Despite their exact origin,
endothelial cells are further specified by Bmp signals emanating from the Nkx2.5 positive
myocardium, and ultimately this induces the endothelium to express the endocardialspecific markers of Nfatc1 and Etsp71 (Ferdous et al., 2009; Palencia-Desai et al., 2015;
Wong et al., 2012). In addition, Bmp is also required in the myocardium to produce key
cardiogenic factors like Nkx2.5 and Mef2c (Chen, 2004). These differentiation signals are
essential to organize the right and left endocardial layers into tubes that will move
medially to fuse together (Kaufman and Navaratnam, 1981). At the same time, the two
cardiogenic plates (which are still continuous with the splanchnic mesoderm) will also
move medially and encapsulate the endocardium. Ventrally, the cardiogenic plates will
fuse, but dorsally, the splanchnic mesoderm will meet and form the dorsal mesoderm
which will fuse at a slower rate. This migration pattern forms a single beating heart tube
of splanchnic mesoderm-derived myocardial cells at E8.0 (Ivanovitch et al., 2017; Kelly
et al., 2014).
Starting at E8.0, the heart tube, now consisting of an outer myocardial cell wall
and an inner endocardium, will start to loop to the right, allowing for the positioning of
the four-chambered heart to take shape (Savolainen et al., 2009). There are four stages of
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cardiac looping: dextral looping, early s-looping, late s-looping, and cardiac septation
(Männer, 2009). Dextral looping, or the ‘c-stage’ of cardiac looping, takes place during
E8.0 to E8.5 and is characterized by the counterclockwise looping of the tube that makes
a distinct C shape (Le Garrec et al., 2017; Männer, 2009). In order from venal to arterial,
there are four prominent swellings of the tube known as the common atrial chamber,
primitive left ventricle, bulbus cordis (primitive right ventricle), and the outflow tract
(Kaufman and Bard, 1999). From E8.5 to E9.5 the s-looping of the heart occurs, again
named after the appearance of the twisting tube which now resembles an S (Le Garrec et
al., 2017; Männer, 2009). Here the bulbus cordis will shift posteriorly to develop into the
right ventricle, and the common atrial chamber will move anteriorly, split into two
chambers, and become the left and right atria (Kaufman and Bard, 1999; Savolainen et
al., 2009). At this point the ventricles will also start to balloon and separate from one
another (Anderson et al., 2006). At E10.5 the atria and ventricles are now in their correct
caudal and rostral positions (Savolainen et al., 2009). To separate these chambers, the
endocardium of the atrioventricular canal and the common outflow tract will undergo
epithelial to mesenchymal transition to create inner wall “cushions” within the cardiac
jelly found between the endocardium and myocardium (Markwald et al., 1977). These
atrioventricular and outflow tract cushions will develop into the needed septal, valvular,
and outflow tract structures of the adult four-chambered heart (Fananapazir and
Kaufman, 1988).
Left/right gene expression plays a critical role in heart looping. For example,
Hand1 and Hand2, regulated by the cardiomyocyte specific gene Nkx2.5 (Lints et al.,
1993), control ventricular differentiation. Hand1 is expressed in the left ventricle while

3

Hand2 is expressed in the right ventricle (Biben and Harvey, 1997; Srivastava et al.,
1997). Looping is also controlled biomechanically by means of the cytoskeletal
components attached to the extra cellular matrix (Hughes and Jacobs, 2017). For
example, flectin is an extracellular protein that has been found to be expressed
asymmetrically around the heart tube during heart morphogenesis (Linask et al., 2003;
Tsuda et al., 1996). Furthermore, if XIN, a gene that maintains the cytoskeleton of
cardiomyocytes, or MMP2, which regulates the extracellular matrix around the heart, is
blocked, the asymmetric cell division that drives the rightward looping of the heart ceases
to initiate in chick embryos (Linask et al., 2005; Wang et al., 1999), indicating a
relationship between the cytoskeletal framework and the extracellular matrix.
A more well-known biophysical force that relates to proper heart development is
hemodynamic force. Blood flow begins at E8.0 when the heart is still just a simple tube,
therefore all the morphological changes of the heart must develop under the continuous
rhythmic process/product of systole (contraction) and diastole (relaxation). The product
of these contractions is blood flow and the forces that are initiated onto the
endothelial/endocardial lining of the cardiovascular system from this flow is termed
hemodynamic force. This force includes both shear stress created as the blood flows over
the endothelial cells (hemodynamic flow) and the pressure exerted on the endothelial wall
from the mere presence of the volume. Together, shear stress and pressure are known as
hemodynamic load (Midgett and Rugonyi, 2014). There is growing evidence to suggest
that the main detector of hemodynamic force is primary cilia found on the apical surface
of endocardial cells (Haack and Abdelilah-Seyfried, 2016; Iomini et al., 2004; Samsa et
al., 2015). This type of signaling, where physical stress is conveyed into biochemical
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signals, is termed mechanotransduction and can be used to initiate developmental
changes of the heart (Hahn and Schwartz, 2009)
One of the morphological features of the heart that is regulated by hemodynamic
force is the trabeculae. Trabeculae are projections of myocardium that extend into the
lumen of the heart and are found at a higher frequency within the ventricles (Sedmera et
al., 2000; Staudt et al., 2014). Trabeculae are thought to have multiple purposes: increase
myocardial mass to aid in contraction, direct the flow of blood to the proceeding heart
chamber, and increase surface area for oxygen absorption before and after the
development of coronary circulation (Goo et al., 2009; Midgett and Rugonyi, 2014).
Even though trabeculae are projections of myocardium, there is still an overlaying layer
of endocardium. Studies in zebrafish have shown that the trabeculae fail to form when
components of the erbB4-erbB2 receptor complex on the myocardium, or the neuregulin
ligand on the endocardium are knocked out of the organism (Gassmann et al., 1995; Lee
et al., 1995; Liu et al., 2010; Meyer and Birchmeier, 1995; Morris et al., 1999;
Peshkovsky et al., 2011). More recently, it has been identified that the activators of this
paracrine signaling are primary cilia found on the endocardium that can respond to shear
stress and activate notch1b (Samsa et al., 2015). The cleaved notch intracellular domain
initiates neuregulin transcription, which further stimulates trabecular growth (GregoBessa et al., 2007; Samsa et al., 2015).
In addition to trabeculation, hemodynamic forces are also responsible for the
signaling required for the formation of valves, ventricle performance, and aortic design
(Combs and Yutzey, 2009; Haack and Abdelilah-Seyfried, 2016; Person et al., 2005). For
example, in zebrafish, valves—endocardial leaflets that prevent reverse blood flow—are
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actually induced through early retrograde blood flow which activates the valve specific
transcription factor klf2a through notch1b signaling (Vermot et al., 2009). Hemodynamic
stress on the outer curvature of the developing ventricle induces cells to elongate (Auman
et al., 2007). Furthermore, redirection of flow during cardiac looping can cause areas of
high and low stress and is responsible for the morphogenesis of symmetrical primitive
left and right aortas into the single left aorta displayed in adults (Hahn and Schwartz,
2009).
Understanding the mechanisms behind heart development is essential for modern
medicine. Disruptions of these innate biological processes can result in death and
debilitation in the form of congenital heart disease (CHD).

Congenital Heart Disease
Congenital heart disease —defined as any malformation of the heart that occurs
prenatally— affects approximately 5 to 10 in 1000 live births, which relates to about 1%
of the population (Greutmann and Tobler, 2012; Hoffman and Kaplan, 2002; Mitchell et
al., 1971). Some common examples of CHDs include abnormalities of the valves
(tricuspid atresia, mitral stenosis), the ventricles (ventricular septal defect, hypoplastic
left heart disease), the atria (atrial septal defect), and the aorta (aortic stenosis). Though
the specific defects depend on the kind of abnormality, most lead to inefficient and/or an
improperly-routed circulation. An example of a defect that causes inefficient circulation
is aortic stenosis, a closing of the aorta that inhibits blood flow out of the heart
(Tworetzky et al., 2004). This abnormality is usually followed by the onset of a
hypoplastic left heart disease (HLHS) where blood flow is further decreased by the
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presence of a small and weakened ventricle (Bardo et al., 2001). Another, and more
common, form of congenital heart disease that leads to inefficient circulation is
ventricular septal defects (VSD). These are hallmarked by the presence of a shunt in the
ventricular septum that normally separates the right and left ventricles. When this defect
is present, there is a mixing of unoxygenated and oxygenated blood, and in extreme cases
(Eisenmenger syndrome) can lead to hypoxia of the entire body, also known as cyanosis
(Minette and Sahn, 2006).
Though CHDs occur in 1% of live births, this frequency is an underestimation. As
most CHDs form during embryonic development, these often lead to embryonic lethality,
and thus go unnoticed (Hoffman, 1995). For infants with CHD that survive past the
embryonic and fetal period, the most lethal time is their first year of life with 48% chance
of mortality; however, if they survive past the first year, then their odds of survival
dramatically increase (Gilboa et al., 2010). From 1987 to 2005, children with CHD were
found to have a 66% decrease in mortality with a 96% chance of surviving to adulthood
(Khairy et al., 2010). This increase in survivability is due to the invention of new surgical
techniques and continuous lifetime healthcare (Greutmann and Tobler, 2012; Seal, 2011;
Thakkar et al., 2017).
One of the best technologies used to circumvent CHD- related deaths, is the
prenatal echocardiography which can be used to detect arrhythmias and
myocardial/ventricular abnormalities in utero (Axt-Fliedner et al., 2006; Nelle et al.,
2009). An abnormality of interest is aortic stenosis, which commonly precedes the
development of hypoplastic left heart syndrome (Tworetzky et al., 2004). When aortic
stenosis is detected, a surgical technique, named balloon valvuloplasty, can be conducted
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at the 21-29 week stage to expand the collapsed aorta and relieve the loading inside the
left ventricle (Tworetzky et al., 2004). A study in 2009 showed that this procedure was
successful in developing a normal biventricular circulation 24% of the time (McElhinney
et al., 2009), but its success rate has since increased to 38% as of 2014 (Freud et al.,
2014).
A surgical intervention used to adapt the body to an already developed
hypoplastic left heart is a three-step surgical method performed within the first year of the
infant’s life (Urencio et al., 2016). The first step is the Norwood procedure, where the
right ventricle is manipulated into becoming the systemic circulator (Bardo et al., 2001).
This is typically followed by the bidirectional Glenn and Fontan procedure to reroute the
superior (Glenn) and inferior (Fontan) vena cava blood directly to the pulmonary artery
for direct oxygenation of the venal blood (Norwood WI, Lang P, 1983; Urencio et al.,
2016).
Ventricular septal defect treatment is determined by the degree of left ventricular
overload which causes an increased ventricular preload (the blood volume present in the
heart before systole). This overload is caused by the direct entrance of blood into the left
ventricle from the right ventricle through the septal shunt (Minette and Sahn, 2006). If
treated, an occlusion device is deployed over the shunt to prevent blood passage. This
treatment was previously done through cardiopulmonary bypass (Arora et al., 2003), but
more recent advances in transcatheter closure is seeing a higher success rate with
minimal improvements needing to be made in the past twenty years (Arora et al., 2004;
Barik, 2016). In this procedure, catheters are used to insert wires into both sides of the
heart via the pulmonary artery or the femoral vein (right), and the femoral, brachial, or
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axillary artery (left). On the left side, the wire is used as a guide to position an Amplazter
device into the VSD. The Amplazter device is a two-part instrument that can be collapsed
for passage into the heart and then expanded once in the VSD. On the right side, a
proximal disc is placed on the other side the Amplazter device and sewn into place to seal
the shunt. This entire procedure is done using echocardiography to visualize the process
(Arora et al., 2004).
These preventive and correctional techniques are an important breakthrough for
survival of these patients; however, better healthcare for fetuses and children is resulting
in a growing population of adults with CHDs, now affecting about 0.5% of individuals
older than eighteen (Marelli et al., 2007; Seal, 2011). Furthermore, since 1987, the deaths
associated with CHD has also shifted from childhood to adulthood (Khairy et al., 2010).
While congenital heart disease has shown a major decrease in the cause of
mortality (Gilboa et al., 2010), it is still a major cause of adult cardiovascular
complications and even premature death (Greutmann and Tobler, 2012). Some of these
complications are atrial tachycardias, which causes rapid and irregular heartbeats (Ávila
et al., 2017), and heart failure due to less efficient blood flow (Nandi et al., 2017).
Pregnant women with CHD have an even higher chance of developing these
complications (Balci et al., 2014; Vitarelli and Capotosto, 2011). There is an estimated
one million adults in the United States living with the effects of congenital heart disease
and this number is predicted to grow as more surgical corrections become available
(Thakkar et al., 2017).
Many CHDs have surgical solutions to them; however, the precise source of the
problem continues to elude the scientific community and therefore warrants further
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investigation. Through animal model studies, molecular approaches to fixing CHD in
utero can become an option. Some of these potential therapeutic approaches include stem
cell therapy to regenerate missing tissues (Wehman et al., 2015), pyruvate dehydrogenase
kinase (PDK) inhibition to rescue the Krebs cycle in the myocardium (Piao et al., 2010),
folic acid supplementation to stabilize the effects of accumulated reactive oxygen species
(Iacobazzi et al., 2016; Qipshidze et al., 2012), and new ways of detecting CHDs can be
accomplished by monitoring abnormal placental mRNAs in the maternal blood stream
(Curti et al., 2016). A more sophisticated approach to molecularly correcting CHD
development might lie in genome editing. In a recent study, Carroll and colleagues were
able to utilize the CRISPR/Cas9 system to induce knockdowns of specific genes in
mouse cardiomyocytes to produce alterations in heart morphology in utero (Carroll et al.,
2016). To utilize these tools for human medicine, we must first understand how
congenital heart diseases arise, and the best way to do that is through studies with animal
models.

Causations of Altered Heart Morphology
Many studies in humans and animal models have revealed that the causes of
CHDs are complex and can be related to genetic, teratogenic and biophysical factors. In
humans, revealing the genetic cause can be done by genetic screening within affected
families, and associating the CHD with specific genetic loci. This results in the
identification of candidate genes involved in CHD formation. However, some loci result
in mutations involving large DNA fragments. For example, about 5% of all CHD patients
have large chromosomal deletions (DiGeorge syndrome) or duplications (Down
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syndrome) (Digilio and Marino, 2016). While these types of studies are helpful in
identifying candidate genes related to CHD, this information does not always link a
specific phenotype to a genotype. Using specific genetic animal knockout models,
researchers have been able to identify specific genes related to CHD. Some of these
genes, namely Nkx2.5, Gata4, Tbx5, Zic3, Tfap2b, Tbx1, and Fog2, encode transcription
factors that are active in the heart (Clark et al., 2006). Others are heart contractility genes
like Myl7/Mlc2a, Ncx1, Tnnt2, and Myh7 (Granados-Riveron and Brook, 2012) and shear
stress responsive genes, such as Nos3 and Klf2 (Groenendijk et al., 2007).
NKX2.5 is known as a major determinant of heart development (Lints et al., 1993;
Lyons et al., 1995) and since it was linked to CHD in 1998 (Schott et al., 1998), many
Nkx2.5 knockout studies performed in mice have identified several morphological
pathways regulated by this gene (Prendiville et al., 2014). For example, Nkx2.5
knockouts disrupt Hand1 expression and cause looping abnormalities (Tanaka et al.,
1999). When Nkx2.5 is conditionally knocked-out in the left ventricle, Bmp10 is overly
expressed and leads to increased trabeculation (Pashmforoush et al., 2004; Schott et al.,
1998). Another gene regulated by Nkx2.5 is the Mlc2v gene which is involved in heart
contractility (Tanaka et al., 1999).
An isoform of Mlc2v is Mlc2a (also known as Myl7 encoding myosin light chain)
and is specific to the atrium. Myl7 mutants display deficient atrium contraction, decreased
ventricular myocardial thickness, and underdeveloped trabeculae (Huang, 2003). This is
also seen in zebrafish that lack the myosin heavy chain (myh6) (Berdougo et al., 2003)
indicating cross-species similarities. This information can be directly related to CHD
because studies in atrial septal defect patients have found that heart contractility genes
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MYL2, MYL3, MYH7, TNNT1 and TNNT3 are downregulated in these patients (Wang et
al., 2016).
Increased myocardium and underdeveloped trabeculae are abnormalities which
commonly occur in CHD patients and, therefore, provide a link between potential gene
targets and CHD development. However, It is becoming clear that single gene mutations
and chromosomal deletions only explain about 25% of CHDs (Russell et al., 2018).
Another important factor to consider is environmental teratogens. A teratogen is any
environmental factor that leads to abnormal development of an embryo. While heart
teratogens are not as extensively studied as genetic causes of CHD (Lage et al., 2012),
some of the known CHD causing teratogens are maternal diseases (influenza and
rubella), therapeutic drugs (ibuprofen, thalidomide) (Jenkins et al., 2007), smoking
(Gianicolo et al., 2010), alcohol consumption (Karunamuni et al., 2014; Shi et al., 2017),
high levels of retinoic acid (Gorini et al., 2014; Lage et al., 2012), and commonly
encountered environmental contaminants like phthalates (PVC flooring) and
alkylphenolic compounds (detergents) (Wang et al., 2013). A specific example of a CHD
teratogen which attracted considerable scientific interest is trichloroethylene.
Trichloroethylene is a known industrial contaminant that can enter human
drinking water (Vogel and McCarty, 1985). Recent evidence shows that chick embryos
exposed to this teratogen exhibit ventricular hypertrophy and hatchlings have an
abnormally high, 38% chance, of having a ventricular septal defect (Rufer et al., 2009).
Additionally, trichloroethylene has also been shown to disrupt calcium homeostasis
regulation necessary for cardiomyocyte function, leading to contractility issues that result
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in altered hemodynamic flow as evidenced by under-expression of shear stress responsive
genes Klf2 and Nos3 (Makwana et al., 2010).
Taken together, the genetic and teratogenic experiments described above share a
common thread in that the effects of altered hemodynamic force, generated through
contractility abnormalities, are indistinguishable from the effects of genetic mutation or
chemical exposure singly. Furthermore, Dll4 knockout mice display a collapsed aorta
which can perturb flow (Anderson et al., 2015), and hypoglycemia (resulting from a
diabetic mother) can decrease the embryonic heart rate (Smoak, 2002). Again, in both
cases, heart abnormalities such as a smaller overall heart, thickened compact
myocardium, and looping defects are exhibited, but these defects cannot be assigned to
the gene/teratogen or to the altered hemodynamics. It is therefore necessary to understand
how hemodynamic force by itself is capable of regulating heart morphogenesis. Several
embryo manipulation studies in chick and zebrafish have attempted to disconnect genetic
and teratogenic effects from those caused by alterations to hemodynamic force itself.
In zebrafish, methods for altering hemodynamic load include glass bead insertion
surgeries (Hove et al., 2003) and centrifugation (Johnson et al., 2015). In the glass bead
surgeries, the bead can be placed at the outflow tract (high load), or at the mouth of the
atrium (low load) to keep blood from exiting or entering the heart respectively. In both
cases, the bulbous (outflow portion of the three chambered fish heart) and atrioventricular
valves fail to develop, and the heart does not loop (Hove et al., 2003)
In chicks, which exhibit a four-chambered heart, similar to that in humans,
methods for altering hemodynamics include ligations of certain parts of the
cardiovascular system to perturb blood flow. Left atrial ligation which perturbs blood
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flow into the left ventricle, creates a low load environment in the left ventricle and a high
load environment in the right ventricle. Outflow tract ligation prevents blood from
leaving the left ventricle and creates a high load in the left ventricle. Vitelline vein
ligation prevents blood from entering the right atrium and creates a heart-wide low
loading affect (Midgett and Rugonyi, 2014). When the vitelline vein of chick embryos is
ligated, the blood flow in the heart is disturbed and leads to unorganized endocardial cell
arrangement; whereas in normal embryos, the endocardial cells arrange to the direction of
flow. Furthermore, the ventricular myocardium has a reduced size and the trabeculation is
reduced (Hogers et al., 1997; Midgett and Rugonyi, 2014). When right (left atrial
ligation) and left (outflow tract ligation) ventricles undergo increased preload, compact
myocardium switches to a hypertrophic state and trabeculae become spiraled and
compacted to compensate for the increased pressure (Midgett and Rugonyi, 2014;
Sedmera et al., 1999).
These studies conclude that hemodynamic force plays a large role in heart
morphogenesis and in turn can lead to CHD. There are obviously similarities in heart
morphogenesis response to hemodynamics through different clades, as evidenced in
similarities found in chick and zebrafish studies, but it is more important for medicinal
reasons to see if these morphological changes are consistent in mammalian hearts. As
Mahler and colleagues summarized, chick and zebrafish are easier and less costly to
experiment on, but they lack placental development and high genetic similarity to
humans which is why mice are more appropriate to study (Mahler and Butcher, 2011).
While there have been some hemodynamic studies in mice (Anderson et al., 2015;
Huang, 2003; May et al., 2004; Weissgerber et al., 2006), these are done using genetic
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knockouts, and as mentioned above, the goal is to alter hemodynamics singly to rule out
all other possible causes of the defects. It can be assumed that mammalian hearts will
respond in a similar manner to altered hemodynamics since chick and zebrafish display
similar phenotypic abnormalities and they are widely separated on the tree of life. The
problem with conducting these studies in mice, until now, pertained to the inability of a
working methodology.

Hypothesis and Derivation of Methodology
Altering hemodynamic force in a mouse embryo is problematic because previous
methods used on zebrafish and chicks would require surgical manipulation of the heart.
Unlike fish and chicks which develop on top of their yolk sac and naturally grow outside
a maternal host, mouse embryos are encased in their yolk sac and are embedded into the
uterus. In vitro culturing of certain stages of a mouse embryo is achievable and has been
done for years, but a key aspect of this technique is keeping the integrity of the yolk sac
unobstructed. This prevents previously established surgical manipulations of the heart
from being utilized. Therefore, for this study, a relatively novel method of reducing
hematocrit (the ratio of blood cells to total volume of the blood) was used, whereby blood
cells were trapped within their spot of origin (i.e. blood islands) located proximal to the
ectoplacental cone of the yolk sac. When blood cells fail to enter circulation, blood flow
continues as normal, but due to the lack of viscosity supplied by the blood cells, there is a
systemic reduction of hemodynamic loading (Lucitti et al., 2007).
With this methodology in hand, a hypothesis can now be tested determining how
low hemodynamic loading will affect mammalian heart development. Based on previous
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results in zebrafish and chick embryos that were forced to undergo reduced hemodynamic
loading through surgical intervention, I hypothesize that the mouse heart will respond to
altered hemodynamic flow in the same way: reduced myocardium, poorly developed
trabecula, and overall less heart growth/development (volume and looping).
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MATERIALS AND METHODS

Mouse Care
Mice were housed in the Missouri State University Temple Hall vivarium
following National Institute of Health (NIH) guidelines. Mice were kept in a standard
Ancare mouse cage and fed Purina Labdiet 5001 in accordance with the Missouri State
Institutional Animal Care and Use Committee (IACUC) protocol #15-008.0-A (approved
on November 20, 2014). Timed dissections were set up by placing a male and female into
a new cage and fed Purina Labdiet 5008 as permitted by IACUC protocol #15-004.0-A
(approved on December 01, 2014). All mice were kept at 20-23˚C under a diurnal cycle
starting at 7 a.m. with 12 hours of light followed by 12 hours of dark.
Mice used in this study were of the CD1 strain and were either homozygous
(Myl7+/+) or heterozygous (Myl7+/-) for the myosin light chain gene involved in heart
contractility. To obtain myosin light chain mutants (Myl7-/-), an E10.5 lethal mutation,
two heterozygous mice were bred resulting in a Mendelian ratio of affected embryos.
Mouse genotyping was performed using DNA extracted from the tip of weaned
mice tails. Dissection scissors were doused in 70% ethanol and then used to clip 1-2mm
off the tip of the tail. The tail cuts were treated with protease K (Thermoscientific, REF
#EO0491) overnight at 55˚C in tail buffer (0.1M NaCl, 0.05M Tris, 0.1M EDTA, 5ml
10% SDS). A 1:1 ratio of phenol-chloroform (Fisher Scientific, BP17531-00) was used to
separate the digested proteins from the DNA, followed by DNA precipitation with
isopropanol and salt removal with 70% ethanol.

17

Mouse DNA was then amplified using polymerase chain reaction (PCR). Two
sets of primers were used to amplify the presence of both the wild type and mutant form
of Myl7: Myl7 wild-type forward primer 5’-GGCACGATCACTC-3’; Myl7 wild-type
reverse primer 5’-ATCCCTGTTCTGG-3’; Myl7 mutant forward primer 5’ACAGGGAATCACA-3’; Myl7 mutant reverse primer 5’-CGAACCTGGTCGA-3’. A
40µl reaction mixture was created using Taq Pro Red Complete (Denville Scientific Inc.,
CB4065-4), genomic DNA and primers. The PCR reaction was completed in a TECHNE
thermocycler (3PRIMEBASE/02) set to denature at 95˚C for five minutes, followed by
35 cycles of denaturing at 95˚C for 30s, annealing for 30s at 56.5˚C, and extending at
72˚C for one minute. This cycle was concluded with a final extension period of five
minutes. The amplicon was then electrophoresed through a 1% agarose gel,
supplemented with 8µl of ethidium bromide, set to 100V. Visualization of the amplified
product was viewed on an Azure Biosystems c300 transilluminator and digital imaging
system.

Timed Embryo Dissections
Timed embryo dissections were set up using Myl7+/+ mice on a CD1 background.
Embryos were dissected eight days (E8.5, somite stage 4-6) after the vaginal plug was
present (E0.5). The mother was sacrificed using CO2 inhalation followed by cervical
dislocation. The uterus was removed from the mother and placed in a 60 mm x 15mm
Petri dish (Falcon®, REF # 351008) with warm, sterile dissection media. Dissection
media consisted of Dulbecco’s Modified Eagle Medium (Gibco®, REF # 11330-032)
with 10% fetal bovine serum (Gibco®, Cat # 10082139) and 1% penicillin/streptomycin
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(Gibco®, REF # 15140-122). Individual embryos were dissected in a custom-made
heater box (cardboard box surrounded by insulating material attached to a space heater),
by removing the myometrium and maternal decidua but keeping the yolk sac intact. Once
dissected, embryos were moved to a 37˚C incubator with 5.0% CO2.

Blood Cell Immobilization
Glass needles were used for injection. 0.4 mm x 75 mm glass capillary tubes
(Drummond Scientific CO., Cat # 1-000-800) were melted and pulled using a MicroData
PMP-102 Micropipette Puller set to the manufacturers default setting SQ20: taper length
of 3 mm, outer diameter of 2-20 µm, and a tip opening of 1-2 µm. Glass needles were
loaded with acrylamide or TEMED using 20 µl Eppendorf GELoader® pipette tips (Cat #
022351656).
The acrylamide mixture was made using 450 µl 2x PBS, 250 µl DiH2O, 250 µl
30% Bis-acrylamide (Fisher Scientific, Cat. # BP1366), 50 µl India ink (American
MasterTech, REF # STIIN25), and 20 µl of 0.5 M ammonium persulfate (Thermo
Scientific, CAS # 7727-54-0). The TEMED mixture consisted of 50 µl TEMED (Fisher
BioReagents, CAS # 110-18-9), 50 µl 2x PBS, and 2 µl of India Ink. Both solutions were
centrifuged at 17xg for one minute and subsequently filter-sterilized using a 0.45 µm
nylon filter (Fisherbrand, Cat # 09-719D) to remove debris.
After dissection, embryo blood islands, located on the yolk sac adjacent to the
ectoplacental cone, were injected three to four times with an acrylamide mixture using a
Pico-Liter Injector (Warner Instruments, PLI-10). TEMED was then injected into the
blood islands to catalyze acrylamide polymerization forming a gel matrix surrounding the
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blood islands and preventing erythrocytes from entering circulation. Embryos were
classified as either no injection controls (Ni), acrylamide-only injected (Ao), or
acrylamide and TEMED injected (AT).

Embryo Static Culturing and Imaging Preparation
After injections, the embryos were moved to a Petri dish containing blood-gassed
(Airgas, REF # 29-400581151-1) culture media (1 part rat serum to 11 parts dissection
media) using a modified transfer pipette (tip cut off for a larger opening). Embryos were
cultured for 24 hours in 37˚C.
After 24 hours, yolk sacs were checked for blood vessel remodeling. Acrylamide
and TEMED treated embryos were checked for a lack of blood vessel remodeling to
indicate blood flow had been successfully reduced (Lucitti et al., 2007). Acrylamide-only
and no injection controls were checked for proper blood vessel remodeling to indicate
normal blood flow.
Embryos were moved to a 1.5ml Eppendorf tube and fixed in 4%
paraformaldehyde (Fisher Scientific, CAS # 30525-89-4) on an oscillator at room
temperature for one hour. After fixation, paraformaldehyde was removed, and embryos
were washed three times with 1x PBS for ten minutes each at room temperature.
To immunostain the embryonic hearts, the embryos were first blocked for one
hour in serum blocking buffer (SBT) consisting of 1x PBS supplemented with 2%
donkey serum (Sigma-Aldrich, Cat # D9663-10ML), and 0.8% Triton X100 (Fisher
Scientific, CAS # 9002-93-1). A 1:250 dilution of Anti-Actin, α Smooth Muscle-Cy3
(sma-cy3; Sigma-Aldrich, Cat # C6198-.2ML) in SBT was used to stain the heart for
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another hour. Embryos were then washed three times with PBS + 0.8% Triton X100. The
embryos were then transferred to a Petri dish of PBS to remove the yolk sac and amnion,
followed by storage in 1% sodium azide PBS at 4˚C.
Optical clearing of the embryos was necessary for optical projection tomography
(OPT) imaging. A 1% agarose PBS solution was boiled (for homogenization), and cooled
to approximately 55˚C. The embryos were inserted into the solution, sucked into a
transfer pipette (tip cut off), and manually rotated- to center the embryo- until the
solution solidified. Agarose embedded embryos were then cut from the transfer pipette,
dehydrated with subsequent washes of 25%, 50%, 75%, and 100% ethanol-PBS
solutions. Embryos were then cleared and stored in a 1:2 benzyl alcohol- benzyl benzoate
(BABB; Fisher Scientific, A396-500; Acros Organics, CAS # 120-51-4) solution.

Optical Projection Tomography Morphometric Analysis
Optical Projection Tomography (OPT) microscopy was selected over
conventional 3D imaging (confocal) due to its ability to generate high-resolution images
of internal structures within the embryonic heart tube. All 3-dimensional imaging was
performed at Baylor College of Medicine utilizing a custom-made OPT microscope and
following previously outlined methods (Singh et al., 2015) as detailed below.
The agarose embedded embryos were shipped to Baylor in 10ml falcon tubes
wrapped in aluminum foil to prevent photobleaching. Upon arrival, samples were stored
at 4˚C. The agar blocks were glued to a metallic chuck and magnetically attached to the
OPT rotational stage. The agarose was submerged in a glass cuvette square filled with
BABB to match the index of refraction of the agar and reduce autofluorescence.
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The OPT excitation laser filter was set to 531nm (green; BP 531/40 filter) and the
emission filter was set to 593nm (red; BP 593/40 filter). The embryos were aligned along
their vertical axes. All embryos were imaged on the same arbitrary zoom setting of
20,000 using an Optem Zoom 125 (0.75X) objective to obtain a final voxel resolution of
2.84um for each image. The embryo was raised out of the cuvette and a series of darkfield pictures were taken. The embryo was lowered back into the BABB and individual
images were captured every 0.3˚ turn of the rotating stage for a total of 1,200 images per
embryo. To view the entire embryo, autofluorescence was obtained using excitation light
through a BP 425/26 filter and captured using a LP 473nm emission filter.
The output bin files were converted to tiff files followed by reconstruction into
3D renditions using NRecon. The 3D renditions were compiled, viewed, and analyzed
using Bitplane’s Imaris®.
Volume. The Imaris Create Surface function was used to quantify the volume of
the developing hearts. Starting at the first indication of sma-cy3 staining, at every ten z
intervals the interior of the heart tube was manually traced to allow an isosurface to be
reconstructed (Fig. 1). The volume of the isosurface was retrieved from the Statistics tab
of the Create Surface interface.
Myocardium Thickness. Utilizing the Imaris Oblique Slicer function, five
optical sections were placed perpendicular to the lumen of the heart tube at equidistant
intervals through the length of the heart (Fig. 2 A-B). On each of the five sections, four
measurements were recorded using the Measurement Points function to record the
distance between the exterior to the interior of the myocardium for a total of twenty
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measurements per heart (Fig. 2 C-D). Measurements were evenly distributed along the
perimeter of the heart tube.
Trabeculation. Trabeculae were quantified using the same five optical sections
used for calculating the myocardial thickness. Trabeculae were parsed from the
surrounding apical myocardium using Adobe Photoshop Channel Mixer function to
convert red trabecular pixels to green. The resulting images had a red myocardium and
underlying green trabeculae (Fig. 2 E). To normalize the amount of trabeculation to the
size of the heart at each slice, a ratio of total pixilation (red and green pixels) to green
pixilation was recorded per optical slice using the ImageJ plugin: Color Pixel Counter.
For heavily looped hearts where optical sections traversed multiple open areas of the
heart, only the lumen of progression was used in the calculations.
To assess the quality of the trabecula, trabecular indents were counted. The Imaris
Create Surface function was utilized under the specification of ‘automatic creation’ using
a surface area detail of 1µm to obtain three dimensional isosurface reconstructions of the
trabecula. The indents formed from intersecting trabecular projections were counted
using this isosurface.
Heart Looping. Ten equidistant optical sections were taken through the length of
the heart. A point was placed in the center of the heart tube lumen at each section using
the Measurement Point function (Fig. 2 F) for a series of connected points from inflow to
outflow labeled A to J. The ends of the line (points A and J) were then aligned along the
transverse plane. Using the joined ends as a vertex, the adjacent arms that dictate the
degree of the angle were drawn towards points B and I to obtain an angle of the heart
helix.
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Developmental Delay
Timed dissections were set up as previously described using Myl7+/- parents on a
CD1 background. The Myl7-/-, +/-, and +/+ embryos were dissected at E9.5 or E10.5 and
somites were counted.

Red Blood Cell Count
Timed embryo dissections, injections, and culturing were conducted as described
above. After culturing for twenty-four hours, embryo diameter was measured using a
microscope stage micrometer. The embryo was then transferred to one milliliter of warm
heparinized PB1 buffer (137mM NaCl, 20mM KCl, 20mM KH2PO4, 143mM Na2HPO42H2O, 10mM MgCl2-6H2O, 100mM glucose, 3.6mM sodium pyruvate, 13.2mM CaCl22H2O, 12.5µg/ml heparin) in a 35x10mm Petri dish (FALCON, REF # 351008) and the
vitelline artery was severed. The still-beating heart pumped the red blood cells (RBC)
into the solution aided by the presence of heparin, an anti-coagulant as shown in previous
studies (Dai et al., 2004). The yolk sac was removed, and the remaining RBCs were
flushed from the vessels by dipping the yolk sac in and out of the PB1 buffer. Somites
were counted and the embryo was removed from the PB1 buffer. The solution of RBCs
was carefully mixed by pipette before moving them to a microcentrifuge tube. Cell
counts were performed on an INCYTO C-Chip hemocytometer (DHC-B02-5) following
the providers instructions: cells in five of the nine large squares were counted, averaged,
and multiplied by 104. As embryonic red blood cells differ from those found in adults,
only relatively large, rounded, nucleated cells (Dai et al., 2004) were counted.
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Statistical Analysis
All morphometric data sets were analyzed using a one-sided t-test, with direction
based on previous findings in chick (Sedmera et al., 1999) and zebrafish (Hove et al.,
2003) embryos. Levene’s test was conducted to prove equal variance. In cases that did
not pass the Levene’s test, a Welch’s t-test (t-test assuming unequal variance) was used in
favor of a non-parametric Mann-Whitney U test due to unequal sample sizes. Two-sided
t-tests were used when analyzing developmental delay and red blood cell counts.
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RESULTS

Rationale and Previously Published Morphometric Findings
A previous study conducted in my lab sought to determine whether low
hemodynamic loaded embryos, created by injection of acrylamide and TEMED (AT) into
the blood islands of cultured E8.5 mouse embryos, would result in aberrant morphology
of the heart. Heart morphology in these embryos were compared to no injection control
embryos (Ni) and acrylamide-only injection control embryos (Ao), because both have
been previously shown to have no effect on yolk sac size, embryo turning, or blood
vessel remodeling (Lucitti et al., 2007), and a qualitative assessment of our control
embryos revealed a similar finding. All three types of embryos were imaged by OPT
microscopy, and morphometric analysis was performed to compare heart structures. In
that previous study conducted in my lab, reducing hemodynamic loading was found to
have no effect on heart volume, but a significant effect on compact myocardial width.
However, in this thesis study, I reviewed the previous findings, and conducted a more
robust statistical analysis of these results. Further, I continued this study, and analyzed
the effects of hemodynamic loading on other aspects of heart development, namely heart
trabeculation and looping.

Low Hemodynamic Loading Decreases Volume Size in E8.5 to E9.5 Embryos
It has been previously shown that increased hemodynamic preload on the left
ventricle leads to a larger volume size (DeAlmeida et al., 2007). I hypothesized that the
low flow environment would have the opposite effect leading to a relative decrease in
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heart volume. Due to the variety of somite stages acquired during the culturing process,
two somite ranges were used to compare the data: 14-16 and 17-19 (Fig. 3 A and B). To
assess volume size, an isosurface of the interior lumen of the heart was constructed (see
methods) and the volume was compared among the treatments (Fig 3 C-E and G-I). In
low loading embryos the volume of the heart was significantly decreased compared to
both Ni and Ao controls in somite range 17-19 (Fig. 3 J), but not in the earlier somite
range 14-16 (Fig. 3 F).

Low Hemodynamic Loading Results in a Decreased Compact Myocardium Width in
E8.5 to E9.5 Embryos
As the heart develops, the endocardium is in direct contact with the flow of blood.
Signals from the endocardium can be relayed to the myocardium to induce proliferation,
hypertrophy, and migration (Haack and Abdelilah-Seyfried, 2016; Peshkovsky et al.,
2011). Optical projection tomography does not allow visualization of individual cellular
growth, but growth of the compact myocardium can still be assessed by measuring the
thickness of the cultured embryo’s heart (Fig. 4 D-F). Twenty width measurements
throughout the length of the heart were collected per individual embryo and, in both
somite ranges, the low hemodynamically loaded hearts showed a significant decrease in
width size (Fig. 4 G and J).
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Low Hemodynamic Loading and Acrylamide-Only Injections Alter Trabeculation
in E8.5 to E9.5 Hearts
Myocardial trabecula of the heart starts to develop as the heart begins beating at
E8.0-E8.5 and has been shown to be altered in both high loading and low loading
environments of chick embryo hearts (Sedmera et al., 1999). Therefore, the next step was
to evaluate how the low loading environment affects trabeculation within a mouse model.
First, the surface area of the trabecula was calculated on six cross-sections per heart
within the three treatment types and normalized to the total myocardium (trabeculated
myocardium and compact myocardium) to prevent bias based on difference in heart size.
When comparing Ni to AT, low hemodynamic loaded hearts exhibited an increase in
trabeculation at both somite stages (Fig. 4 H and K). Unexpectedly, the acrylamide-only
controls also showed an increase in trabeculated myocardium compared to the no
injection controls. Upon visual inspection of the cross-sections, the trabecula of Ni had
more projections in the lumen of the heart; whereas the Ao and AT hearts displayed
compacted trabecula (Fig. 4 D-F). This characteristic can also be seen when viewing the
entire surface of the outer curvature of the heart (Fig. 4 A-C).
To quantify these findings, trabecular ‘indents’ were counted. Trabecular indents
are defined as the depression that forms when adjacent trabecular projections connect.
The results showed that hearts under a normal hemodynamic loading environment
develop more trabecular indents at both somite stages (Fig. 4 I and L). Again, the
acrylamide-only treated embryos displayed decreased numbers of trabecular indents
similar to that seen in the low loading embryos. Taken together, these observations
indicate that low hemodynamic loading does not stop trabecula from forming, but it does
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inhibit it from forming correctly. Furthermore, acrylamide-only injections are also
capable of affecting trabecula similar to the AT injected treatments.

Low Hemodynamic Loading and Acrylamide-Only Injections Inhibit Proper Heart
Tube Looping in E8.5 to E9.5 Embryos
Despite observing defects in trabeculation in acrylamide-only embryos, the
morphological assessment proceeded to gauge how hemodynamic loading affects heart
tube looping. Looping is an imperative feature of mammalian heart development because
this process allows the primitive ventricle to separate into left and right portions which
subsequently separates the pulmonary and systemic circulations. In previous studies,
heart looping has been measured by comparing the atrioventricular junction to the
anteroposterior axis (Parrie et al., 2013); however, this study was performed in zebrafish
which has a simplified degree of looping. Therefore, a style more fitted for threedimensional analysis, that has been confirmed to be reliable in mice (Le Garrec et al.,
2017), was used instead. The interior looping helix of the heart was manually created, the
extremities of this helix were aligned to form a circular shape along the transverse plane
and an angle of the transverse helix was measured using the aligned extremities as the
vortex of the angle (Fig. 5 A-I). In this manner, low loaded hearts (AT) at both somite
ranges were found to be in a more linear state compared to Ni controls, and Ao injections
also resulted in linearized hearts closely resembling those of the AT model (Fig. 5 J-K).
In summary, low hemodynamic loading prevents proper heart tube looping, but following
a trend observed in the trabeculation studies, Ao injections also inhibited looping.
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Low Hemodynamic Loading Causes Developmental Delay in E8.5 to E9.5 Embryos
To address the question of why the Ao controls had a significant effect on
trabeculation and looping of the heart, the qualitative assessment of the control and
experimental embryos —that cultured Ao embryos resembled Ni embryos— was
revisited by quantifying somites to determine whether the embryos exhibit developmental
delay. To test this, timed dissections were performed at E8.5 (somite stage 4-6) followed
by blood island injections. These injections consisted of the normal injection types (Ni,
Ao, and AT) but also included PBS only (Po) and TEMED only (To). After culturing for
twenty-four hours, the embryos’ somites were counted and compared to both the noinjection control and the PBS injection, since these should have no effect on the embryo’s
development. The individual injections did not significantly alter the development of the
embryos as shown with an average somite count of eighteen between all treatment types
including Ao (Table 1), demonstrating that all control embryos do not exhibit
developmental delay. However, the low hemodynamic loaded embryos, exhibited a
significant developmental delay (p-value = 0.001 to Ni treatment, p-value = 0.005 to PBS
treatment) by only reaching an average somite stage of 14 (Table 1). This was an
expected result, because it was previously published that the low hemodynamic loading
embryos also exhibit an impairment to other aspects of development, including smaller
yolk sac, impaired turning, and an inability for the vessels to remodel (Lucitti et al.,
2007)
The observed developmental delay brings up another question concerning the
validity of the AT model, as addition of acrylamide and TEMED could synergistically
have an effect on remodeling that is independent of reduced-hemodynamic loading. To
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prove that developmental delay was caused by reduced-loading, and not the synergistic
action of acrylamide and TEMED, the extent of development was compared between
Myl7 mutants (Myl7 -/-) to wild type controls (Myl7 wt). Myl7 (also known as Mlc2a) is a
protein coding gene (myosin light chain) essential for atrial contractions of the cardiac
muscle of the heart (Huang, 2003). When this protein is absent (Myl7 -/-), blood flow is
reduced, and in these embryos, quantitative analysis of the somites revealed a significant
developmental delay of in vivo embryos at both E9.5 and E10.5 (Table 2). Since Myl7
mutants (genetically altered low-loading) display a similar phenotype to the AT injected
embryos (physically altered low-loading), it can be concluded that the developmental
delay is likely caused by reduced-loading, and not a direct effect of the AT treatment.

Acrylamide Decreases the Number of Systemic Primitive Red Blood Cells at E9.5
When acrylamide was injected into the blood islands of E8.5 embryos and
cultured for twenty-four hours, the blood vessels of the yolk sac properly remodeled—
indicating adequate levels of hemodynamic force (Lucitti et al., 2007)— and
somitogenesis was unperturbed (Table 1). However, trabeculation and heart tube looping
of Ao embryos more closely resembled those of the low hemodynamic loaded embryos
(Fig. 4 and 5). Since the hemodynamic loading was sufficient in remodeling the yolk sac
and allowing proper heart volume/myocardial thickness development, but insufficient in
promoting trabeculation and heart tube looping, I wanted to address if hemodynamic
force was being negatively modulated enough to exhibit some, but not all, morphological
changes.
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During developmental stages E8.5 to E11.5 proerythroblasts are transitioning into
polychromatic erythroblasts (Dai et al., 2004; Palis, 2014), and according to a recent
study, polychromatic erythroblasts in adult rats have an increased chance of becoming
micronucleated- a sign of genotoxicity- when orally administered acrylamide (Yener,
2013). Furthermore, adult rats also exhibit reduced hematocrit, and their red blood cell
counts are low due to osmotic fragility and oxidative stress (Ghorbel et al., 2015). Even
though these studies were conducted in adult rats, the potential for acrylamide to reduce
the number of red blood cells circulating within mouse embryos did not seem unjustified.
To test the hypothesis that acrylamide can reduce red blood cell numbers within
E8.5-9.5 embryos, injections were performed as normal, embryos were cultured for
twenty-four hours, red blood cells were collected (see methods), and then counted on a
hemocytometer. Since the RBC collection method by design could not possibly collect
every red blood cell found in the embryos, somite range and yolk sac diameter size of the
collected embryos were first compared to make sure there were no obvious dissimilarities
between levels of development that would account for further variations in RBC
numbers. The average yolk sac diameter was 2.5mm and the average somite count was 16
among Ni and Ao embryos used for RBC counting (Table 3). Furthermore, there was no
correlation between yolk sac size and the number of erythrocytes found within these
embryos as indicated by the low R-squared values found in both Ni (-0.0499) and Ao
(0.0229) (Fig. 6). Due to this lack of correlation, there should be no growth bias
influencing RBC numbers in the embryos. Therefore, all of the collected embryos in the
RBC assessment were used and a significant 38% decrease in red blood cells was found
in the Ao treatments compared to Ni treatments (p-value = 0.010, Table 4). This decrease
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in RBC could potentially explain the abnormalities of trabeculation and looping
displayed in Ao embryos.
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Table 1. Developmental Delay of Different Injection Types in Terms of Somite Stage.
E8.5 embryos were injected with different combinations of polymerizing chemicals and
somites were counted after culturing for twenty-four hours. The p-values are based on a
two-sided t-test.
p-value
Injection Type

n

Somite Number

To No Injection

To PBS

No injection

12

18.3 ± 2.6

-

0.693

PBS

9

17.8 ± 0.9

0.693

-

TEMED

9

17.6 ± 1.5

0.479

0.580

Acrylamide

26

18.3 ± 3.7

0.961

0.742

Acrylamide + TEMED

27

14.4 ± 3.4

* 0.001

* 0.005
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Table 2. Developmental Delay of Myl7 Mutants in Terms of Somite Stage. Timed
dissections were performed on E9.5 or E10.5 embryos, somites were counted, and
embryos were genotyped. The p-value was based on a two-sided t-test.
E9.5

Somites
p-value

E10.5

Myl7 wt

Myl7 -/-

Myl7 wt

Myl7 -/-

23.7 ± 1.1

22.4 ± 1.5

35.4 ± 2.1

30.8 ± 2.3

* 0.010

* <0.001
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Table 3. Yolk Sac and Somite Comparison of No Injection and Acrylamide-Only Injected
Embryos. The yolk sac (YS) diameter and somite stage was compared between embryos
that were either not injected or injected with acrylamide and cultured for twenty-four
hours. The p-values are based a two-sided t-test.
Injection Type
No Injection
Acrylamide-only
p-value

n
18
18

YS Diameter
2.5 ± 0.4
2.5 ± 0.3
0.849
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Somites
16 ± 3
15 ± 3
0.186

Table 4. Red Blood Cell Count in No Injection and Acrylamide-Only Injected Embryos.
Red blood cells were drained from cultured embryos that received the indicated
treatments and counted. The p-values are based on a two-sided t-test.
Injection Type
No Injection
Acrylamide-only
p-value

N
18
18

RBC Count
3.66e5 ± 1.54e5
2.28e5 ± 1.48e5
*0.010
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Figure 1. Isosurface Creation for Volume Comparison. The sma-cy3 fluorescence was
visualized in three-dimensions and on transverse, optical cross-sections, the lumen of the
heart was traced to create an isosurface. (A) Side view of the sma-cy3 fluorescence on the
embryo’s heart. (B) Side view and (C) dorsal view of the sma-cy3 fluorescence with
layered lumen tracings. (D) Side view of the Imaris-constructed isosurface (translucent)
of the heart with layered lumen tracings. (E) Imaris-constructed isosurface.
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Figure 2. Method Visualization for Myocardial Thickness, Trabeculation, and Heart
Looping Analysis. Optical cross-sections were placed through the length of the heart for
morphometric analysis. (A) Isosurface side view of the heart. (B) Isosurface with crosssections (only first and last cross-sections for clarity). (C) Cross-section without
manipulation. (D) Cross-section with four myocardial-width measurements. (E) Crosssection with trabeculated myocardium parsed out in green. (F) Cross-section with a single
point in the center of the lumen of progression (arrow points to the point), used for heart
looping.
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Figure 3. Isosurface and Volume Comparison of E8.5-E9.5 Mouse Hearts. Isosurfaces
were created (A-B) from the autoflourescent OPT images to visualize the entire embryo,
or (C-E, G-I) from the sma-cy3 immunostaining to visualize just the volume of the heart.
(A-B) Representative whole embryo isosurfaces (A: Ni, somite range 14-16; B: Ni,
somite range 17-19) with hearts manually colored red and somites marked with white
arrows. (C-E, G-I) Representative images of whole heart volumes for somite range 14-16
(C: Ni, D: Ao, E: AT) and 17-19 (G: Ni, H: Ao, I: AT). (F, J) Boxplots of heart volume
for each treatment type with indicated p-values based on a one-tailed t-test. A-B scale bar
= 300µm; C-E, G-I scale bar = 100µm. F n= 3 (Ni), 6 (Ao), 12 (AT); J n = 5 (Ni), 8 (Ao),
7 (AT).

40

Figure 4. Myocardial Thickness and Trabeculation Comparison of E8.5 to E9.5 Mouse
Hearts. (A-C) Representative images of the en face view of the interior lumen of the
primitive ventricle with the slice position indicated by the superimposed image, and the
white arrows denoting the presence of trabecular ‘indents’ (A: Ni, B: Ao, C: AT). (D-F)
Representative optical sections of the interior lumen of the heart with the slice position
indicated by the superimposed image, measured compact myocardium is labeled red, and
the trabeculated myocardium is labeled green; A = Atrium, V = Ventricle, OFT =
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Outflow Tract (D: Ni, E: Ao, F: AT). (G-L) Boxplots and indicated p-values for
myocardial thickness (G, J), trabeculated area (H, K), and trabecular indents (I, L). The pvalues were obtained using a Welch’s t-test (G, J) and a one-sided t-test (H-I, K-L). A-F
scale bar = 70µm. G-I n= 3 (Ni), 6 (Ao), 12 (AT); J-L n = 5 (Ni), 8 (Ao), 7 (AT).
Myocardial thickness used 20 (n x 20) measurements per heart, and trabeculation to total
surface tests used six measurements per heart (n x 6).
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Figure 5. Heart Tube Looping Comparison of E8.5 to E9.5 Embryos. A-I Isosurface
reconstructions of the heart tube with interior looping helix shown as a series of ten
equidistant connected dots; A-C: Ni, D-F: Ao, G-I: AT. (A, D, G) ventral view. (B, E, H)
left view. (C, F, I) Show the anterior view of the heart with the transverse helix angle
overlying the aligned helix extremities. (J, K) Boxplots of the calculated transverse
angles and indicated p-values based on a one-sided t-test. Scale bar = 70µm. J n= 3 (Ni),
6 (Ao), 12 (AT); K n = 5 (Ni), 8 (Ao), 7 (AT).
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Figure 6. Lack of Correlation Between Red Blood Cell Count and Yolk Sac Diameter.
Scatterplots of red blood cell (RBC) counts compared to yolk sac diameter for no
injection controls (A) and acrylamide-only injections (B). Adjusted R-squared values
indicate no correlation.
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DISCUSSION

This study shows that lowering the hemodynamic load in mouse embryos,
through the prevention of red blood cell entry into the circulatory system, results in
abnormalities to heart size, myocardial thickness, trabeculation, and looping.
Furthermore, acrylamide can result in a reduction of circulating red blood cells (a
probable sign of reduced hematocrit) and can also impair some aspects of heart
development like trabeculation and looping.
The defects present in low-loaded embryos included a reduction in heart volume
size (only present in later stage embryos) and a decrease in myocardial thickness. This
corroborates previous findings in chicks where both volume and compact myocardial
thickness where reduced in experimentally altered low-loaded left ventricles (Sedmera et
al., 1999).
Low-loaded embryos and Ao embryos both resulted in compact trabeculation and
more linearized heart tubes. Again, these defects were expected as similar results were
shown previously in embryos with reduced hemodynamic loading; however, acrylamide
by itself was not expected to affect heart morphology. This led to experiments which
assessed the validity the utilized methods by looking at developmental delay in
genetically and physically altered embryos.
The effects of acrylamide treatment on heart development begs the question as to
why the acrylamide polymerization approach was used in the first place. There are two
main reasons to justify this approach. First, injection of acrylamide alone into the blood
islands did not impair blood vessel development or somitogenesis (Table 1), so it was not
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expected to affect heart development (Lucitti et al., 2007). Second, there was not a better
option for a polymerizing agent that can prevent blood cells from entering circulation.
Acrylamide is commonly known as a neurotoxin (LoPachin and Gavin, 2012), and while
non-toxic gelling agents exist, such as hydrogels (synthesized from poly(vinyl alcohol)),
there are still problems that can arise when using them. For example, polymerizing
molecules are intrinsically electrophilic. This property allows the molecule to create the
necessary covalent bonds needed for gel formation. However, many biological
macromolecules are nucleophilic, leading to easy bond formation, and therefore toxicity,
with the electrophilic polymerizing molecules (LoPachin and Gavin, 2012). Also,
catalyzing the polymerization reaction of non-toxic gels, such as hydrogels, is
accomplished through harmful reactants/initiators like formaldehyde, UV-irradiation, and
gamma rays (Ahmed, 2015). Therefore, caveats were bound to form no matter what
method was chosen.
In this study, it was shown that acrylamide-only injections did not cause
developmental delay, but acrylamide and TEMED injections did. To confirm that a
lowered hemodynamic load was causing developmental delay and not a synergistic effect
of the acrylamide and TEMED acting together, developmental delay was assessed in
genetically modified mice that have reduced hemodynamic load through Myl7 knockout.
These mice also exhibited developmental delay and confirmed that the synergistic action
of acrylamide and TEMED together was not the cause of developmental delay. It should
be noted that the premise of this project was to leave altered genetics out of the study to
assess how hemodynamic loading by itself affects development; however, the use of this
data helped validate the utilized methods.
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While acrylamide by itself might impair heart development in other ways, like
direct interaction with the heart or through altered signaling achieved by protein
degradation, here it was shown that acrylamide reduced the amount of circulating red
blood cells (Table 4). Considering that hematocrit levels determine blood viscosity, and
viscosity affects the amount of hemodynamic force (Secomb, 2016), I propose that
treatment of acrylamide alone may partly reduce the hemodynamic load. In this way it
seems hemodynamic signaling acts in a continuum in its ability to modulate heart
develop, where low levels of hemodynamic load (no blood cells in circulation; AT)
results in defects of volume size, compact myocardial thickness, trabeculation, and
looping, but medium levels of hemodynamic loading (a reduced number of circulating
blood cells; Ao) results in trabeculation and looping defects. This correlates with
previous studies performed on chick embryos where different amounts of hemodynamic
loading, modulated by the extent of conotruncal binding, can lead to different types of
CHD (Midgett et al., 2017). Furthermore, Hogers and colleagues showed that decreased
hemodynamic loading by vitelline vein ligation still resulted in 36% of the chicks having
a normally developed heart (Hogers et al., 1997). In chicken models with low
hemodynamic loading through left atrial ligation, the cells of the left ventricle showed
decreased proliferation, and diminished myosin immunostaining (decreased contractile
function) (Sedmera et al., 2002), but in a study looking at the effect of high hemodynamic
loading, there was increased myocardial proliferation (DeAlmeida et al., 2007). These
studies indicate that there is a threshold that must be passed for hemodynamic load to
affect morphogenesis. Thus, in future studies, it may be interesting to test if increasing
the hemodynamic load has an opposite effect on heart development. This could
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potentially be done by culturing mouse embryos in erythropoietin, which has been shown
to increase hematocrit levels (Mary E. Dickinson, Ph.D., Baylor College of Medicine,
personal communication).
There is still much to learn pertaining to how hemodynamics affect heart
morphology. For example, hypoplastic left heart syndrome typically forms secondary to
aortic stenosis. In contrast, simulating aortic stenosis, via conotruncal binding
experiments, results in an opposite phenotype of left ventricular hypertrophy (Sedmera et
al., 1999). There is speculation that the longer gestation period in humans is what causes
this difference, whereby hypoplastic left heart disease develops as a coping method for
the continuous and elongated time that the stress caused by the increased afterload can be
inflicted on the human heart during develop (Krishnan et al., 2014). However, in adults
that develop aortic stenosis, the heart’s coping method does result in left ventricular
hypertrophy (Grimard et al., 2016), the condition seen in experimental chick embryos.
This data, along with a study done in zebrafish which showed that altered hemodynamic
loading only affects heart morphology at a certain time during development (Johnson et
al., 2015), indicates that hemodynamic load can act in different ways at different time
points. Future studies may need to evaluate time-dependent factors by altering
hemodynamic loading in different stage embryos.
Based on this study, decreased hemodynamic loading negatively impacts
morphogenesis of the mammalian heart, and if development were to continue, it would
likely give rise to a congenital heart defect. In people, low hemodynamic loading could
be caused by multiple reasons, but one that is equivalent to this study is anemia (a lack of
red blood cells in circulation), which has a high association with CHD (El-Koofy et al.,
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2017; Miyamoto et al., 2015). In a recent study, women who supplemented their diet with
folic acid —a common treatment for adult anemia because it promotes erythropoiesis—
before and during their pregnancy were shown to have a decreased risk of delivering a
child with CHD (Mao et al., 2017). Additionally, ethanol-induced CHD in zebrafish
embryos can be corrected with the addition of folic acid (Sarmah and Marrs, 2013). In
mouse embryos, ethanol was further shown to alter lipid-related gene expression in the
heart which was, again, corrected with folic acid (Linask and Han, 2016). Whether or not
folic acid aided in altering the hemodynamics of these embryos was not investigated.
As eluded to above, it is likely that a continued low-loading scenario would give
rise to a congenital heart defect. Thus, it would be ideal to extend this study past the E9.5
stage of mouse heart development, so that the morphology of other structures that form
later (such as septate and valves) could be assessed. However, one caveat is to overcome
is the limitations of mouse embryo culture. It is possible that mouse embryos can be
manipulated and cultured up until E12.5, but this requires enhanced technical skills, and
other pieces of equipment (roller bottles attached to gas line) (Yashiro et al., 2007).
Further, embryos cannot currently be cultured past E12.5, but there is an in vivo
technique called the exo utero development system which allows for surgical exposure of
the embryos (to allow for experimental manipulations) followed by closure and continued
growth within the mother. As this technique is also limited by the presence of the
amniotic sack, doing surgical interventions like suturing can still be problematic (Yamada
et al., 2008).
In addition to assessing the impact of hemodynamic loading on later staged
hearts, another future direction would be to determine the molecular mechanisms by
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which the heart responds to hemodynamic load. As mentioned before in the introduction,
non-motile cilia have been found to be responsive to shear stress and this signaling is
necessary for trabecula development. It is hypothesized that non-motile cilia undergo
mechanotransduction because the cilia become deflected with flow, and presumably this
causes mechanical stretching and activation of receptors at the membrane (Samsa et al.,
2015). Since cilia are gaining prevalence as the main detector of shear stress, these
studies on hemodynamic load are gaining more importance as a link to CHD
development. In validation of this discovery, defects in cilia development and function
have recently been correlated with CHD development in mice through a large-scale
mutagenesis screen (Klena et al., 2017) and ciliopathies are heavily associated with
heterotaxy which is defined as any condition where heart defects are found
simultaneously with other organ defects (Russell et al., 2018). In addition to cilia,
evidence from endothelial cells suggest other possible modes of mechanotransduction
that may also need to be explored: from stretching of adherens junctions (induced by
pressure forces), to activation of ion channels (Haack and Abdelilah-Seyfried, 2016).
Therefore, the next step in this process should be to understand how the heart is
responding to hemodynamic load on a cellular level.
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